Remission maintenance
Showing 1 - 25 of 9,078
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)
Recruiting
- Giant Cell Arteritis
- Methotrexate
- Sodium chloride
-
Bonn, GermanyMedical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022
Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)
Not yet recruiting
- Autoimmune Diseases
- placebo
- mycophenolate mofetil
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 26, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)
Not yet recruiting
- Non-radiographic Axial Spondyloarthritis
- Secukinumab
- Placebo
- (no location specified)
Nov 16, 2022
Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)
Not yet recruiting
- Multiple Myeloma
- +2 more
- Discontinuation of maintenance treatment
-
Cork, IrelandCork University Hospital
May 10, 2023
Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)
Not yet recruiting
- Diffuse Large B-cell Lymphoma (DLBCL)
-
Lanzhou, Gansu, ChinaThe First Hospital of Lanzhou University
Oct 23, 2022
Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)
Not yet recruiting
- Progression Free Survival
- +2 more
- Ixazomib DX/Lenalidomide DX
- (no location specified)
Jul 27, 2022
Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Aug 18, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Springfield (Omega Nutrition cold-milled
Completed
- Epithelial Ovarian Cancer
- +2 more
- Omega Nutrition cold-milled flaxseeds
-
Springfield, IllinoisSouthern Illinois University School of Medicine
Mar 30, 2022
Bipolar Depression, Suicidal Ideation Trial in United States (NRX-101, Lurasidone HCl)
Active, not recruiting
- Bipolar Depression
- Suicidal Ideation
- NRX-101
- Lurasidone HCl
-
Birmingham, Alabama
- +3 more
Aug 9, 2022
Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Feb 9, 2022
Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker
Completed
- Alkylating Agent-Related Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
- Laboratory Biomarker Analysis
- Lenalidomide
-
Houston, TexasM D Anderson Cancer Center
Oct 18, 2022
Maintenance of Remission With Pentasa as Ulcerative Colitis
Completed
- Ulcerative Colitis
-
Zutphen, NetherlandsGelre Ziekenhuizen (there may be other sites in this country)
May 16, 2022
MDD, Recurrent, in Remission Trial (Negative ion therapy, Light therapy)
Not yet recruiting
- Major Depressive Disorder, Recurrent, in Remission
- Negative ion therapy
- Light therapy
- (no location specified)
Jul 19, 2022
Crohn's Disease Trial in Worldwide (Modified Exclusive Enteral Nutrition, Crohn's Disease Exclusion Diet, Partial Enteral
Completed
- Crohn's Disease
- Modified Exclusive Enteral Nutrition
- +3 more
-
Edmonton, Canada
- +6 more
May 29, 2022
Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)
Recruiting
- Idiopathic Pulmonary Hemosiderosis
- Leflunomide
- Leflunomide
- Steroid Drug
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023
Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)
Recruiting
- Acute Myeloid Leukemia
- Decitabine and Cedazuridine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- Rituximab, Methotrexate, Temozolomide
-
Paris, FranceGroupe Hospitalier Pitie Salpetriere
Feb 10, 2022
Ulcerative Colitis Trial (Intravenous (IV) infusions)
Not yet recruiting
- Ulcerative Colitis
- Intravenous (IV) infusions
- (no location specified)
Mar 14, 2023
Steroid-Dependent Nephrotic Syndrome Trial in Kolkata (Rituximab, Mycophenolate Mofetil)
Active, not recruiting
- Steroid-Dependent Nephrotic Syndrome
- Rituximab
- Mycophenolate Mofetil
-
Kolkata, West Bengal, IndiaNilratan Sircar Medical College and Hospital
Apr 6, 2022